OpenAlex
PricingAboutJobs
Log inGet started
Work

Discontinued disease-modifying therapies for Alzheimer’s disease: status and future perspectives

HTML

Year: 2020
Type: review
Source: Expert Opinion on Investigational Drugs
DOI: 10.1080/13543784.2020.1795127
Authors: Bruno P. Imbimbo, Madia Lozupone, Mark Watling, Francesco Panza
Institutions: Chiesi (Italy), University of Bari Aldo Moro
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: Alzheimer's disease, disease-modifying therapy, drug discontinuation, amyloid-beta, anti-amyloid drugs, tau hyperphosphorylation, neuroinflammation, anti-inflammatory agents, apolipoprotein E, immunomodulation, plasma exchange, protein clearance, autophagy, mitochondrial dysfunction, glucose metabolism, neurovascular unit, epigenetic dysregulation, synaptic dysfunction, dysbiosis, drug repurposing, combination therapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3041641412
FWCI: 0.624
Cites: 147
Cited by: 31
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security